Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Coliseum Capital Likes Jamba Juice

Coliseum Capital, Jamba: Christopher Shackelton and Adam Gray‘s hedge fund Coliseum Capital disclosed initiating a position in Jamba, Inc.(NASDAQ:JMBA). According to the 13G filing, Coliseum now holds around 1.05 million shares of the company, which represent 6.1% of its common stock.

Jamba, Inc. (NASDAQ:JMBA)

Disclosure: none

Recommended Reading:

Jana Partners Goes Activist on QEP Resources, Seeks Spinoff and Share Repurchase

Israel Englander Raises Stake in Spectrum Pharmaceuticals

Mario Gabelli, Gamco Raise Stake in The L.S. Starrett Company to 15%

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!